Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

[New insight into the airway remodeling of asthma:IgE].

Miao WW, Wang FF, Liu HY, Yin KS, Zhou LF.

Zhonghua Jie He He Hu Xi Za Zhi. 2013 May;36(5):367-70. Review. Chinese. No abstract available.

PMID:
24047813
2.

Can anti-IgE therapy prevent airway remodeling in allergic asthma?

Rabe KF, Calhoun WJ, Smith N, Jimenez P.

Allergy. 2011 Sep;66(9):1142-51. doi: 10.1111/j.1398-9995.2011.02617.x. Epub 2011 Jun 7. Review.

3.

Anti-IgE: a significant breakthrough in the treatment of airway allergic diseases.

Louis R.

Allergy. 2004 Jul;59(7):698-700. No abstract available.

4.

Inhibitory effects of anti-immunoglobulin E antibodies on airway remodeling in a murine model of chronic asthma.

Kang JY, Kim JW, Kim JS, Kim SJ, Lee SH, Kwon SS, Kim YK, Moon HS, Song JS, Park SH, Lee SY.

J Asthma. 2010 May;47(4):374-80. doi: 10.3109/02770901003801972.

PMID:
20528589
5.

Serum IgE Induced Airway Smooth Muscle Cell Remodeling Is Independent of Allergens and Is Prevented by Omalizumab.

Roth M, Zhao F, Zhong J, Lardinois D, Tamm M.

PLoS One. 2015 Sep 2;10(9):e0136549. doi: 10.1371/journal.pone.0136549. eCollection 2015.

6.

What effect does asthma treatment have on airway remodeling? Current perspectives.

Durrani SR, Viswanathan RK, Busse WW.

J Allergy Clin Immunol. 2011 Sep;128(3):439-48; quiz 449-50. doi: 10.1016/j.jaci.2011.06.002. Epub 2011 Jul 12. Review.

PMID:
21752441
7.

Effects of treatment with anti-immunoglobulin E antibody omalizumab on airway inflammation in allergic asthma.

Djukanović R, Wilson SJ, Kraft M, Jarjour NN, Steel M, Chung KF, Bao W, Fowler-Taylor A, Matthews J, Busse WW, Holgate ST, Fahy JV.

Am J Respir Crit Care Med. 2004 Sep 15;170(6):583-93. Epub 2004 Jun 1.

PMID:
15172898
8.

[Anti-IgE therapy].

Chazan R.

Pneumonol Alergol Pol. 2002;70 Suppl 1:76-81. Review. Polish. No abstract available.

PMID:
12518645
9.

[On asthma and allergic reactions. Omalizumab: from IgE to anti-IgE].

Ladetzki-Baehs K, Dirsch VM, Vollmar AM.

Pharm Unserer Zeit. 2004;33(2):116-22. Review. German. No abstract available.

PMID:
15083621
10.

[Anti-IGE therapy in asthma].

Mehiri Ben Rhouma N, Béji M, Louzir B, Daghfous J.

Tunis Med. 2002 Oct;80(10):575-80. Review. French.

PMID:
12632749
11.

[Pneumology. Anti-IgE antibodies in the treatment of asthma].

Leuenberger P, Sauty A, Rochat T.

Rev Med Suisse. 2007 Jan 10;3(93):56-9. Review. French.

PMID:
17354662
12.

Developing antibodies for targeting immunoglobulin and membrane-bound immunoglobulin E.

Chang TW.

Allergy Asthma Proc. 2006 Mar-Apr;27(2 Suppl 1):S7-14. Review.

PMID:
16722326
13.

Anti-IgE and other new immunomodulation-based therapies for allergic asthma.

Jonkers RE, van der Zee JS.

Neth J Med. 2005 Apr;63(4):121-8. Review.

14.

[IgE regulation in asthma pathogenesis and development of a monoclonal anti-IgE antibody for the treatment of allergic asthma].

Wang G, Wang ZL.

Zhonghua Jie He He Hu Xi Za Zhi. 2003 Jul;26(7):427-30. Review. Chinese. No abstract available.

PMID:
14649229
15.

Omalizumab (Xolair): an anti-IgE antibody for asthma.

[No authors listed]

Med Lett Drugs Ther. 2003 Aug 18;45(1163):67-8. No abstract available.

PMID:
12915804
16.

Three months' administration of anti-IgE to a patient with Churg-Strauss syndrome.

Giavina-Bianchi P, Giavina-Bianchi M, Agondi R, Kalil J.

J Allergy Clin Immunol. 2007 May;119(5):1279; author reply 1279-80. Epub 2007 Mar 8. No abstract available.

PMID:
17349685
17.

Anti-IgE and chemotherapy: a critical appraisal of treatment options for severe asthma.

Walters EH, Walters JA, Wood-Baker R.

Expert Opin Pharmacother. 2007 Apr;8(5):585-92. Review.

PMID:
17376014
18.

The potential of biologics for the treatment of asthma.

Pelaia G, Vatrella A, Maselli R.

Nat Rev Drug Discov. 2012 Dec;11(12):958-72. doi: 10.1038/nrd3792. Review.

PMID:
23197041
19.

Anti-IgE treatment in asthma: galectin-3 as a predictive marker.

Moretta L, Pistoia V.

Immunol Lett. 2014 Nov;162(1 Pt A):1. doi: 10.1016/j.imlet.2014.09.012. Epub 2014 Sep 18. No abstract available.

PMID:
25241018
20.

Anti-IgE therapy results in decreased myeloid dendritic cells in asthmatic airways.

Chand HS, Schuyler M, Joste N, Hensler C, Tesfaigzi Y, Masten B, Schrader R, Lipscomb MF.

J Allergy Clin Immunol. 2010 May;125(5):1157-1158.e5. doi: 10.1016/j.jaci.2010.01.020. Epub 2010 Mar 20. No abstract available.

Items per page

Supplemental Content

Write to the Help Desk